Publication date: Sep 30, 2024
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Jill Foster, MD Guest: John Russell, MD According to recent studies, co-administering the flu, RSV, and COVID-19 vaccines is generally safe, which is why both the CDC and Advisory Committee on Immunization Practices support this approach. However, there are some important considerations to keep in mind when co-administering these three respiratory vaccines, which is why Dr. Mary Katherine Cheeley speaks with Drs. Jill Foster and John Russell about best practices for co-administration and improving vaccination rates. Dr. Foster is the Director of the Division of Pediatric Infectious Diseases at the University of Minnesota Medical School, and Dr. Russell is a family medicine physician at Jefferson Health System in Abington, Pennsylvania.
| Concepts | Keywords |
|---|---|
| December | Administering |
| Drugstores | Bit |
| July | Covid |
| Texas | Doctor |
| Vaccine | Flu |
| Foster | |
| Giving | |
| Know | |
| Rsv | |
| Russell | |
| Time | |
| Vaccination | |
| Vaccine | |
| Vaccines | |
| Year |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | IDO | host |
| drug | DRUGBANK | Calusterone |
| disease | MESH | Infectious Diseases |
| drug | DRUGBANK | Nonoxynol-9 |
| disease | IDO | site |
| drug | DRUGBANK | Tropicamide |
| pathway | REACTOME | Immune System |
| drug | DRUGBANK | Etoperidone |
| disease | IDO | country |
| disease | MESH | common cold |
| disease | MESH | influenza |
| drug | DRUGBANK | Coenzyme M |